Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.20.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 18,357 $ 49,724
Other current assets 2,665 2,409
Total current assets 21,022 52,133
Investment in Charter, accounted for using the equity method (note 4) 12,194,726 12,194,674
Other assets 9,406 9,535
Total assets 12,225,154 12,256,342
Current liabilities:    
Accounts payable and accrued liabilities 4,260 6,168
Deferred revenue and other current liabilities 3,850 5,971
Total current liabilities 8,110 12,139
Debt (note 5) 573,269 572,944
Deferred income tax liabilities 992,704 999,757
Other liabilities 4,100 3,556
Total liabilities 1,578,183 1,588,396
Equity    
Preferred stock, $.01 par value. Authorized 50,000,000 shares; no shares issued
Additional paid-in capital 7,876,950 7,890,084
Accumulated other comprehensive earnings, net of taxes 8,158 8,158
Retained earnings (accumulated deficit) 2,760,043 2,767,885
Total equity 10,646,971 10,667,946
Commitments and contingencies (note 7)
Total liabilities and equity 12,225,154 12,256,342
Series A common stock    
Equity    
Common stock 265 265
Series B common stock    
Equity    
Common stock 25 25
Series C common stock    
Equity    
Common stock $ 1,530 $ 1,529